Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Parallel-Group Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)
Conditions
Interventions
Lemborexant
Lemborexant
+3 more
Locations
102
United States
Jasper Summit Research LLC
Jasper, Alabama, United States
PACT
Glendale, Arizona, United States
Preferred Research Partners
Little Rock, Arkansas, United States
Carlsbad, California, United States
Southern California Research
Fountain Valley, California, United States
Pacific Sleep Medicine Services
Oceanside, California, United States
Start Date
May 31, 2016
Primary Completion Date
January 30, 2018
Completion Date
January 30, 2018
Last Updated
November 12, 2024
NCT06032377
NCT06807086
NCT06181643
NCT07429578
NCT05780814
NCT06348082
Lead Sponsor
Eisai Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions